Bulletin
Investor Alert

London Markets Close in:

Regeneron Pharmaceuticals Inc.

NAS: REGN

GO
/marketstate/country/us

Market open

/zigman2/quotes/203149337/composite

$

647.78

Change

-4.10 -0.63%

Volume

Volume 126,092

Sep 20, 2021, 11:28 a.m.

Real time quotes

/zigman2/quotes/203149337/composite

Previous close

$ 651.88

$ 647.78

Change

-4.10 -0.63%

Day low

Day high

$643.63

$652.00

Open
Open: 643.84

52 week low

52 week high

$441.00

$686.62

Open

Market cap

$69.72B

Average volume

724,068

P/E ratio

11.62

Rev. per Employee

$931,393

EPS

55.70

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/regn

MarketWatch News on REGN

  1. Regenxbio Stock Soars on AbbVie Eye Therapy Partnership

    10:10 a.m. Sept. 13, 2021

    - Josh Nathan-Kazis

  2. Regeneron started at buy with $763 stock price target at UBS

    11:38 a.m. Sept. 9, 2021

    - Tomi Kilgore

  3. Why Atea Could Be the Frontrunner in the Covid Antiviral Race

    10:55 a.m. Sept. 9, 2021

    - Josh Nathan-Kazis

  4. Regeneron stock price target raised to $727 from $636 at Benchmark

    6:29 a.m. Aug. 23, 2021

    - MarketWatch

  5. U.K. approves antibody treatment cocktail for COVID-19

    6:48 a.m. Aug. 20, 2021

    - Steve Goldstein

  6. Federal Health Officials Announce Booster Plan as Covid Cases Climb

    11:29 a.m. Aug. 18, 2021

    - Josh Nathan-Kazis

  7. Regeneron Stock Jumps as GOP Governors Boost Its Antibody Therapy

    11:03 a.m. Aug. 18, 2021

    - Josh Nathan-Kazis

  8. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/regn

Other News on REGN

  1. Glaxo's (GSK) Nucala Gets CHMP Nod for 3 Diseases in Europe

    8:12 a.m. Today

    - Zacks.com

  2. Sanofi/Regeneron's Libtayo combo improved overall survival in lung cancer patients

    12:38 a.m. Today

    - Seeking Alpha

  3. AbbVie's Pain Is Sanofi's and Regeneron's Gain

    5:57 a.m. Sept. 18, 2021

    - Motley Fool

  4. Biogen (BIIB) Reports Mixed Data From Neuropathy Pain Study

    10:58 a.m. Sept. 17, 2021

    - Zacks.com

  5. Regeneron, Lilly Get New COVID Drug Deals From Government

    11:28 a.m. Sept. 16, 2021

    - Zacks.com

  6. Aerie (AERI) Announces Mixed Data From Dry Eye Disease Study

    11:19 a.m. Sept. 16, 2021

    - Zacks.com

  7. Company News for Sep 16, 2021

    8:39 a.m. Sept. 16, 2021

    - Zacks.com

  8. Smart Investors Are Watching This Trend Right Now

    6:00 a.m. Sept. 16, 2021

    - Motley Fool

  9. REGENXBIO (RGNX) Stock Up on Collaboration Deal With AbbVie

    10:55 a.m. Sept. 14, 2021

    - Zacks.com

  10. Eyes Have It in AbbVie Deal With Regenxbio

    5:26 p.m. Sept. 13, 2021

    - GuruFocus.com

  11. Loading more headlines...
/news/pressrelease/company/us/regn

Press Releases on REGN

  1. Regeneron Pharmaceuticals REGN Investment Report

    11:20 p.m. July 24, 2021

    - Stock Traders Daily

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.